| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
44,360,000 |
| Market
Cap: |
55.23(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.9693 - $2.87 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 4.5 |
| Insider 6 Months : 4.5 |
| Insider 3/6 Months : 9.3 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Immunic is a clinical-stage biopharmaceutical company. Co. is pursuing three development programs. These include the vidofludimus calcium (IMU-838) program, which is focused on the development of oral formulations of a small molecule inhibitor of the enzyme dihydroorotate dehydrogenase; the IMU-935 program, which is focused on an inverse agonist of retinoic acid receptor-related orphan nuclear receptor gamma truncated, an immune cell-specific isoform of retinoic acid receptor-related orphan nuclear receptor gamma; and the IMU-856 program, which involves the development of a drug targeting the restoration of intestinal barrier function and regeneration of bowel epithelium.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
14,000 |
14,000 |
14,000 |
122,500 |
| Total Buy Value |
$18,333 |
$18,333 |
$18,333 |
$174,157 |
| Total People Bought |
1 |
1 |
1 |
3 |
| Total Buy Transactions |
1 |
1 |
1 |
8 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Satter Muneer A |
Director |
– • • |
2017-06-14 |
4 |
B |
$3.10 |
$31,008 |
I/I |
10,000 |
10,952,277 |
2.25 |
- |
|
| Bienaime Jean Jacques |
Director |
– • – |
2017-06-13 |
4 |
B |
$3.00 |
$48,069 |
D/D |
16,000 |
55,119 |
2.39 |
- |
|
| Satter Muneer A |
Director |
– • • |
2017-06-13 |
4 |
B |
$3.03 |
$30,311 |
I/I |
10,000 |
10,942,277 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2017-06-12 |
4 |
B |
$3.06 |
$30,615 |
I/I |
10,000 |
10,932,277 |
2.25 |
- |
|
| Ashley Robert A. |
Chief Technical Officer, EVP |
• – – |
2017-06-09 |
4 |
B |
$3.18 |
$6,360 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
| Satter Muneer A |
Director |
– • • |
2017-06-09 |
4 |
B |
$3.17 |
$31,733 |
I/I |
10,000 |
10,922,277 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2017-06-08 |
4 |
B |
$3.10 |
$30,958 |
I/I |
10,000 |
10,912,277 |
2.25 |
- |
|
| Nash Duane |
President |
• – – |
2017-06-08 |
4 |
B |
$3.12 |
$12,182 |
D/D |
3,900 |
8,224 |
2.74 |
- |
|
| Satter Muneer A |
Director |
– • • |
2017-06-07 |
4 |
B |
$3.21 |
$32,074 |
I/I |
10,000 |
10,902,277 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2017-06-06 |
4 |
B |
$3.19 |
$31,940 |
I/I |
10,000 |
10,892,277 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2017-03-27 |
4 |
B |
$4.00 |
$15,000,000 |
I/I |
3,750,000 |
10,882,277 |
2.25 |
- |
|
| Nash Duane |
President |
• – – |
2016-12-23 |
5 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
4,324 |
|
- |
|
| Hasnain Faheem |
Director |
– • – |
2016-08-12 |
4 |
B |
$5.92 |
$699,999 |
D/D |
118,243 |
122,743 |
2.39 |
- |
|
| Hasnain Faheem |
Director |
– • – |
2016-08-11 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
4,500 |
|
- |
|
| Hasnain Faheem |
Director |
– • – |
2016-08-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,500 |
|
- |
|
| Hasnain Faheem |
Director |
– • – |
2016-08-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
122,743 |
|
- |
|
| Winters Terence E. |
Co-Chairman and CEO |
• • – |
2016-06-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
184,966 |
|
- |
|
| Winters Terence E. |
Co-Chairman and CEO |
• • – |
2015-12-23 |
5 |
GD |
$0.00 |
$0 |
D/D |
3,600 |
186,966 |
|
- |
|
| Satter Muneer A |
Director |
– • • |
2015-10-28 |
4 |
B |
$5.50 |
$2,200,000 |
I/I |
400,000 |
7,132,277 |
2.25 |
- |
|
| Dunn John Michael |
General Counsel and Secretary |
• – – |
2015-10-26 |
4 |
B |
$7.00 |
$14,000 |
D/D |
2,000 |
9,385 |
2.74 |
- |
|
| Cohen Cheryl |
Director |
– • – |
2015-10-26 |
4 |
B |
$7.17 |
$25,090 |
I/I |
3,500 |
3,500 |
2.1 |
- |
|
| Dunn John Michael |
General Counsel and Secretary |
• – – |
2015-10-23 |
4 |
B |
$6.76 |
$49,933 |
D/D |
7,385 |
7,385 |
2.74 |
- |
|
| Winters Terence E. |
Co-Chairman and CEO |
• • – |
2015-09-14 |
4 |
OE |
$0.43 |
$55,004 |
D/D |
128,394 |
190,566 |
|
- |
|
| Bienaime Jean Jacques |
Director |
– • – |
2015-09-10 |
4 |
B |
$3.05 |
$18,293 |
D/D |
6,000 |
39,119 |
2.39 |
- |
|
| Bienaime Jean Jacques |
Director |
– • – |
2015-09-09 |
4 |
B |
$3.07 |
$24,800 |
D/D |
8,000 |
33,119 |
2.39 |
- |
|
113 Records found
|
|
Page 3 of 5 |
|
|
